CoChat

The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.

Recent developments in the use of nanoparticles for treatment of biofilms

Open access
Han, Chendong, Romero, Nicholas, Fischer, Stephen, Dookran, Julia, Berger, Aaron, Doiron, Amber L. · 2017 · Nanotechnology Reviews

Abstract

Chronic infections have posed a tremendous burden on health care systems worldwide. Approximately 60% of chronic infections are estimated to be related to biofilms, in large part due to the extraordinary antibiotic resistance of biofilm bacteria. Nanoparticle (NP)-based therapies are viable approaches to treat biofilm-associated infections due to NPs’ unique chemical and physical properties, granted by their high surface area to volume ratio. The mechanism underlying the anti-biofilm activity of various types of NPs is actively under investigation. Simply comparing biofilm disruption or reduction rates is not adequate to describe the effectiveness of NPs; many other factors need to be taken into account, such as the NP type, bacterial strain, concentration of NPs, quantification methods, and the biofilm culture environment. This review focuses on recent research on the creation, characterization, and evaluation of NPs for the prevention or treatment of biofilm infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1515/ntrev-2016-0054

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 141 references

Research works printed but not linked: 149

  1. 2007, Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry, Appl. Environ. Microbiol., 73, 3283, 10.1128/AEM.02750-06 · DOI · Paper page
  2. 2011, Biofilm on artificial pacemaker: fiction or reality?, Arq. Bras. Cardiol., 97, e113
  3. 2014, Externally controlled triggered-release of drug from PLGA micro and nanoparticles, PLoS One, 9, e114271, 10.1371/journal.pone.0114271 · DOI
  4. 1987, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc. Natl. Acad. Sci. USA., 84, 9265, 10.1073/pnas.84.24.9265 · DOI · Paper page
  5. 2006, Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles, Langmuir, 22, 9322, 10.1021/la060661v · DOI · Paper page
  6. 2012, Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells, Int. J. Nanomedicine, 7, 1805
  7. 2014, Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control, Int. J. Nanomedicine, 9, 2635
  8. 2015, Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria, Cytotechnology, 67, 427, 10.1007/s10616-014-9701-8 · DOI
  9. 2006, Antimicrobial properties of copper plasma-modified polyethylene, Polymer, 47, 7441, 10.1016/j.polymer.2006.08.057 · DOI
  10. 2012, Nanomaterials for targeted detection and photothermal killing of bacteria, Chem. Soc. Rev., 41, 3193, 10.1039/c2cs15340h · DOI · Paper page
  11. 2014, Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa, J. Nanobiotechnology, 12, 2, 10.1186/1477-3155-12-2 · DOI · Paper page
  12. 2014, Antibacterial efficacy of iron-oxide nanoparticles against biofilms on different biomaterial surfaces, Int. J. Biomater., 2014, 716080
  13. 2014, Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies, J. Biotechnol., 191, 121, 10.1016/j.jbiotec.2014.09.003 · DOI · Paper page
  14. 2011, Influence of copper ions on the viability and cytotoxicity of Pseudomonas aeruginosa under conditions relevant to drinking water environments, Int. J. Hyg. Environ. Health, 214, 485, 10.1016/j.ijheh.2011.06.004 · DOI
  15. 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
  16. 2015, Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity, J. Mater. Sci. Mater. Med., 26, 1
  17. 2012, Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm, Int. J. Nanomedicine, 7, 3245
  18. 2010, Antibiotic resistance of bacterial biofilms, Int. J. Antimicrob. Agents., 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
  19. 2013, Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms, Orthop. Rev., 5, 65
  20. 2015, Mucosal biofilm detection in chronic otitis media: a study of middle ear biopsies from Greenlandic patients, Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg., 272, 1079
  21. 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245 · DOI · Paper page
  22. 2009, Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation, Nat. Chem. Biol., 5, 913, 10.1038/nchembio.242 · DOI · Paper page
  23. 1987, Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses, Arch. Surg. Chic. Ill 1960., 122, 38
  24. 2013, Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori?, World J. Gastroenterol., 19, 6645, 10.3748/wjg.v19.i39.6645 · DOI
  25. 2015, One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa, Biofouling, 31, 379, 10.1080/08927014.2015.1048686 · DOI · Paper page
  26. 1987, Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses, Arch. Surg. Chic. Ill 1960., 122, 38
  27. 2001, Biofilms and device-associated infections, Emerg. Infect. Dis., 7, 277, 10.3201/eid0702.010226 · DOI · Paper page
  28. 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
  29. 2012, Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection, Int. J. Nanomedicine, 7, 4053
  30. 2014, Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data, Lancet Infect. Dis., 14, 742, 10.1016/S1473-3099(14)70780-7 · DOI · Paper page
  31. 1998, The pharmacodynamics of aminoglycosides, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 27, 23, 10.1086/514620 · DOI · Paper page
  32. 2013, Nanotechnology as a therapeutic tool to combat microbial resistance, Adv. Drug Deliv. Rev., 65, 1803, 10.1016/j.addr.2013.07.011 · DOI · Paper page
  33. 2014, Therapeutic strategies to combat antibiotic resistance, Adv. Drug Deliv. Rev., 78, 14, 10.1016/j.addr.2014.10.027 · DOI · Paper page
  34. 2013, Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan, BMC Ophthalmol., 13, 57, 10.1186/1471-2415-13-57 · DOI
  35. 1992, Sensitization of oral bacteria to killing by low-power laser radiation, Curr. Microbiol., 25, 77, 10.1007/BF01570963 · DOI · Paper page
  36. 2012, An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles, Nanomed. Nanotechnol. Biol. Med., 8, 916, 10.1016/j.nano.2011.11.007 · DOI · Paper page
  37. 2015, Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide, Colloids Surf. B Biointerfaces., 135, 717, 10.1016/j.colsurfb.2015.08.027 · DOI
  38. 2011, Detection of extended spectrum beta lactamases, ampc beta lactamases and metallobetalactamases in clinical isolates of ceftazidime resistant Pseudomonas Aeruginosa, Braz. J. Microbiol., 42, 1284, 10.1590/S1517-83822011000400006 · DOI
  39. 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
  40. 2014, Synthesis and surface immobilization of antibacterial hybrid silver-poly(l-lactide) nanoparticles, Nanotechnology., 25, 305102, 10.1088/0957-4484/25/30/305102 · DOI
  41. 2015, Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro, Int. J. Pharm., 495, 728, 10.1016/j.ijpharm.2015.09.055 · DOI
  42. 2015, Synthesis and antimicrobial activity of monodisperse copper nanoparticles, Colloids Surf. B Biointerfaces, 128, 17, 10.1016/j.colsurfb.2015.02.009 · DOI · Paper page
  43. 2009, Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis, Microbiol. Read. Engl., 155, 2148, 10.1099/mic.0.028001-0 · DOI · Paper page
  44. 2002, Biofilms as complex differentiated communities, Annu. Rev. Microbiol., 56, 187, 10.1146/annurev.micro.56.012302.160705 · DOI · Paper page
  45. 2009, The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay, Biomaterials, 30, 5979, 10.1016/j.biomaterials.2009.07.030 · DOI · Paper page
  46. 2012, Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting, Proc. Jpn. Acad. Ser. B., 88, 53, 10.2183/pjab.88.53 · DOI · Paper page
  47. 2008, Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives, J. Controlled Release, 125, 193, 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
  48. 1999, Measuring antimicrobial effects on biofilm bacteria: from laboratory to field, Methods Enzymol., 310, 608, 10.1016/S0076-6879(99)10047-8 · DOI
  49. 2015, Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm, PLoS One, 10, e0131806, 10.1371/journal.pone.0131806 · DOI
  50. 2012, Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm, Int. J. Nanomedicine, 7, 3245
  51. 2014, Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria, Nanoscale Res. Lett., 9, 373, 10.1186/1556-276X-9-373 · DOI · Paper page
  52. 2004, Silver nanoparticles as antimicrobial agent: a case study on E. coli as amodel for Gram-negative bacteria, J. Colloid Interface Sci., 275, 177, 10.1016/j.jcis.2004.02.012 · DOI · Paper page
  53. 2000, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0 · DOI · Paper page
  54. 2008, Drug delivery and nanoparticles: applications and hazards, Int. J. Nanomed., 3, 133
  55. 2010, The biofilm matrix, Nat. Rev. Microbiol., 8, 623, 10.1038/nrmicro2415 · DOI · Paper page
  56. 2013, Magnetic nanoparticle targeted hyperthermia of cutaneous Staphylococcus aureus infection, Ann. Biomed. Eng., 41, 598, 10.1007/s10439-012-0698-x · DOI · Paper page
  57. 2015, Chelating and antibacterial properties of chitosan nanoparticles on dentin, Restor. Dent. Endod., 40, 195, 10.5395/rde.2015.40.3.195 · DOI
  58. 1994, Role of alginate lyase in cell detachment of Pseudomonas aeruginosa, Appl. Environ. Microbiol., 60, 2355, 10.1128/AEM.60.7.2355-2359.1994 · DOI · Paper page
  59. 2012, A method for quantitative determination of biofilm viability, J. Funct. Biomater., 3, 418, 10.3390/jfb3020418 · DOI · Paper page
  60. 2001, How to optimize the drop plate method for enumerating bacteria, J. Microbiol. Methods, 44, 121, 10.1016/S0167-7012(00)00241-4 · DOI · Paper page
  61. 2010, Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy, Powder Technol., 203, 432, 10.1016/j.powtec.2010.06.003 · DOI
  62. 2011, Antimicrobial effect of chitosan nanoparticles on streptococcus mutans biofilms, Appl. Environ. Microbiol., 77, 3892, 10.1128/AEM.02941-10 · DOI · Paper page
  63. 2006, Biofilms: implications in bioremediation, Trends Microbiol., 14, 389, 10.1016/j.tim.2006.07.001 · DOI · Paper page
  64. 2005, The resistance of polyvinylpyrrolidone-iodine-poly(-caprolactone) blends to adherence of Escherichia coli, Biomaterials, 26, 2013, 10.1016/j.biomaterials.2004.06.001 · DOI
  65. 2013, Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms, PLoS One, 8, e79220, 10.1371/journal.pone.0079220 · DOI
  66. 2013, Biocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation, Mater. Lett., 97, 67, 10.1016/j.matlet.2013.01.085 · DOI
  67. 2012, Doxil®–the first FDA-approved nano-drug: lessons learned, J. Control. Release Off. J. Control. Release Soc., 160, 117, 10.1016/j.jconrel.2012.03.020 · DOI · Paper page
  68. 1998, Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase, Microbiol. Read. Engl., 144, 3039, 10.1099/00221287-144-11-3039 · DOI · Paper page
  69. 2014, Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms, J. Controlled Release, 195, 21, 10.1016/j.jconrel.2014.07.061 · DOI
  70. 1998, The involvement of cell-to-cell signals in the development of a bacterial biofilm, Science, 280, 295, 10.1126/science.280.5361.295 · DOI · Paper page
  71. 2005, Persister cells and the riddle of biofilm survival, Biochem. Biochemistry (Moscow), 70, 267, 10.1007/s10541-005-0111-6 · DOI · Paper page
  72. 2011, ‘Persisters’: survival at the cellular level, PLoS Pathog., 7, e1002121, 10.1371/journal.ppat.1002121 · DOI
  73. 2004, Polyurethane vascular catheter surface grafted with zwitterionic sulfobetaine monomer activated by ozone, Colloids Surf. B Biointerfaces, 35, 1, 10.1016/j.colsurfb.2004.01.005 · DOI
  74. 2012, Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy, Int. J. Nanomedicine, 7, 49
  75. 2007, Magnetic nanoparticles: synthesis, protection, functionalization, and application, Angew. Chem. Int. Ed., 46, 1222, 10.1002/anie.200602866 · DOI · Paper page
  76. 2013, Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles, ACS Appl. Mater. Interfaces, 5, 9322, 10.1021/am402618w · DOI · Paper page
  77. 2012, Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles, Particuology, 10, 327, 10.1016/j.partic.2011.08.007 · DOI
  78. 2014, Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen, Mater. Sci. Eng. C, 41, 91, 10.1016/j.msec.2014.04.035 · DOI
  79. 2010, Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis, Colloids Surf. B Biointerfaces, 79, 340, 10.1016/j.colsurfb.2010.04.014 · DOI · Paper page
  80. 1999, Bacterial biofilms: a common cause of persistent infections, Science., 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  81. 2005, An investigation of the thermal inactivation of Staphylococcus aureus and the potential for increased thermotolerance as a result of chilled storage, J. Appl. Microbiol., 99, 1229, 10.1111/j.1365-2672.2005.02697.x · DOI
  82. 2008, Prevention of hospital-acquired infections: review of non-pharmacological interventions, J. Hosp. Infect., 69, 204, 10.1016/j.jhin.2008.03.018 · DOI · Paper page
  83. 2008, On the mechanisms of biocompatibility, Biomaterials, 29, 2941, 10.1016/j.biomaterials.2008.04.023 · DOI · Paper page
  84. 2000, Molecular mechanisms that confer antibacterial drug resistance, Nature., 406, 775, 10.1038/35021219 · DOI · Paper page
  85. 2012, Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics, ACS Nano., 6, 4279, 10.1021/nn3008383 · DOI · Paper page
  86. 2011, Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm, Int. J. Mol. Sci., 12, 5039, 10.3390/ijms12085039 · DOI · Paper page
  87. 2012, Synthesis and antimicrobial activity of copper nanoparticles, Mater. Lett., 71, 114, 10.1016/j.matlet.2011.12.055 · DOI · Paper page
  88. 2012, Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci, Acta Biomater., 8, 2047, 10.1016/j.actbio.2012.03.002 · DOI · Paper page
  89. 2016, Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery, Carbohydr. Polym., 138, 114, 10.1016/j.carbpol.2015.11.072 · DOI
  90. 2014, Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms, PLoS One, 9, e103234, 10.1371/journal.pone.0103234 · DOI
  91. 2013, Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action, Colloids Surf. B Biointerfaces, 102, 300, 10.1016/j.colsurfb.2012.07.039 · DOI · Paper page
  92. 2015, Strategies for combating bacterial biofilm infections, Int. J. Oral Sci., 7, 1, 10.1038/ijos.2014.65 · DOI · Paper page
  93. 2014, Ferromagnetic nanoparticles with peroxidase-like activity enhance the cleavage of biological macromolecules for biofilm elimination, Nanoscale, 6, 2588, 10.1039/C3NR05422E · DOI · Paper page
  94. 2006, Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance, Investig. Opthalmology Vis. Sci., 47, 1416, 10.1167/iovs.05-0495 · DOI · Paper page
  95. 2015, Enhancing the stability and antibiofilm activity of DspB by immobilization on carboxymethyl chitosan nanoparticles, Microbiol. Res., 178, 35, 10.1016/j.micres.2015.06.001 · DOI
  96. 2007, Removal of heavy metals from aqueous systems with thiol functionalized superparamagnetic nanoparticles, Environ. Sci. Technol., 41, 5114, 10.1021/es0705238 · DOI · Paper page
  97. 2001, Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials, J. Bacteriol., 183, 6746, 10.1128/JB.183.23.6746-6751.2001 · DOI · Paper page
  98. 2002, Biodegradable nanoparticles for drug delivery and targeting, Curr. Opin. Solid State Mater. Sci., 6, 319, 10.1016/S1359-0286(02)00117-1 · DOI · Paper page
  99. 2008, Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates, J. Microbiol. Methods, 72, 157, 10.1016/j.mimet.2007.11.010 · DOI · Paper page
  100. 2005, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications, Biomaterials, 26, 3995, 10.1016/j.biomaterials.2004.10.012 · DOI · Paper page
  101. 2014, Magnetic hyperthermia with magnetic nanoparticles: a status review, Curr. Top. Med. Chem., 14, 572, 10.2174/1568026614666140118203550 · DOI · Paper page
  102. 2011, Influence of scaffold size on bactericidal activity of nitric oxide releasing silica nanoparticles, ACS Nano, 5, 7235, 10.1021/nn202054f · DOI
  103. 2009, Characterisation of copper oxide nanoparticles for antimicrobial applications, Int. J. Antimicrob. Agents, 33, 587, 10.1016/j.ijantimicag.2008.12.004 · DOI · Paper page
  104. 2011, The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics, Colloids Surf. Physicochem. Eng. Asp., 389, 158, 10.1016/j.colsurfa.2011.08.035 · DOI
  105. 2014, Effect of copper salts and reducing agents on characteristics and antimicrobial activity of copper nanoparticles, Mater. Lett., 132, 307, 10.1016/j.matlet.2014.06.014 · DOI
  106. 2012, Antibacterial properties of nanoparticles, Trends Biotechnol., 30, 499, 10.1016/j.tibtech.2012.06.004 · DOI · Paper page
  107. 2013, Validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests, Vet. Res. Forum, 4, 179
  108. 2000, Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin, Antimicrob. Agents Chemother., 44, 1818, 10.1128/AAC.44.7.1818-1824.2000 · DOI · Paper page
  109. 2012, An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo, Antimicrob. Agents Chemother., 56, 972, 10.1128/AAC.05680-11 · DOI
  110. 2015, Metal-based antibacterial substrates for biomedical applications, Biomacromolecules, 16, 1873, 10.1021/acs.biomac.5b00773 · DOI · Paper page
  111. 2009, Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles, Biomaterials, 30, 2782, 10.1016/j.biomaterials.2009.01.052 · DOI · Paper page
  112. 2011, Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity, Eur. J. Med. Chem., 46, 1103, 10.1016/j.ejmech.2011.01.025 · DOI
  113. 2013, Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era, Cold Spring Harb. Perspect. Med., 3, a010306
  114. 1981, Preparation of aqueous magnetic liquids in alkaline and acidic media, IEEE Trans. Magn., 17, 1247, 10.1109/TMAG.1981.1061188 · DOI · Paper page
  115. 2015, Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains, J. Biomater. Appl., 30, 269, 10.1177/0885328215578781 · DOI
  116. 2003, A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli, J. Microbiol. Methods, 55, 475, 10.1016/S0167-7012(03)00194-5 · DOI · Paper page
  117. 2015, Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity, J. Mater. Sci. Mater. Med., 26, 1
  118. 2015, Current development of silver nanoparticle preparation, investigation, and application in the field of medicine, current development of silver nanoparticle preparation, investigation, and application in the field of medicine, J. Nanomater. J. Nanomater., 2015, e696918, 10.1155/2015/696918 · DOI · Paper page
  119. 2008, Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections, J. Antimicrob. Chemother., 61, 859, 10.1093/jac/dkn059 · DOI · Paper page
  120. 2000, Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms, Nature, 407, 762, 10.1038/35037627 · DOI · Paper page
  121. 2014, Iron oxide nanoparticles induce Pseudomonas aeruginosa growth, induce biofilm formation, and inhibit antimicrobial peptide function, Environ. Sci. Nano, 1, 123, 10.1039/c3en00029j · DOI
  122. 2010, Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo, Proc. Natl. Acad. Sci. USA., 107, 22038, 10.1073/pnas.1010341107 · DOI · Paper page
  123. 2012, Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol, J. Agric. Food Chem., 60, 6150, 10.1021/jf3010405 · DOI
  124. 2015, Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy, Sci. Rep., 5, 18385, 10.1038/srep18385 · DOI
  125. 2011, Biofilm on artificial pacemaker: fiction or reality?, Arq. Bras. Cardiol., 97, e113
  126. 2014, Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen, Nanomedicine Nanotechnol. Biol. Med., 10, 491, 10.1016/j.nano.2013.10.010 · DOI · Paper page
  127. 2010, Structure-based drug design and optimization of mannoside bacterial FimH antagonists, J. Med. Chem., 53, 4779, 10.1021/jm100438s · DOI · Paper page
  128. 2003, Antimicrobial resistance of Pseudomonas aeruginosa biofilms, Microbes Infect., 5, 1213, 10.1016/j.micinf.2003.08.009 · DOI · Paper page
  129. 2003, Chitosan as antimicrobial agent: applications and mode of action, Biomacromolecules, 4, 1457, 10.1021/bm034130m · DOI · Paper page
  130. 2007, Synthesis of nitric oxide-releasing silica nanoparticles, J. Am. Chem. Soc., 129, 4612, 10.1021/ja0674338 · DOI · Paper page
  131. 2001, Riddle of biofilm resistance, Antimicrob. Agents Chemother., 45, 999, 10.1128/AAC.45.4.999-1007.2001 · DOI · Paper page
  132. 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob. Agents Chemother., 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
  133. 2005, Introduction: antibiotic resistance, Chem. Rev., 105, 391, 10.1021/cr030100y · DOI · Paper page
  134. 2002, Mechanisms of antibiotic resistance in bacterial biofilms, Int. J. Med. Microbiol., 292, 107, 10.1078/1438-4221-00196 · DOI · Paper page
  135. 2011, Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester, Carbohydr. Polym., 83, 438, 10.1016/j.carbpol.2010.08.004 · DOI · Paper page
  136. 2010, Antibiotic resistance and its cost: is it possible to reverse resistance?, Nat. Rev. Microbiol., 8, 260, 10.1038/nrmicro2319 · DOI · Paper page
  137. 2005, Sociomicrobiology: the connections between quorum sensing and biofilms, Trends Microbiol., 13, 27, 10.1016/j.tim.2004.11.007 · DOI · Paper page
  138. 2014, Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms, Antimicrob. Agents Chemother., 58, 5818, 10.1128/AAC.03170-14 · DOI
  139. 1983, Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation, Immunology, 49, 37
  140. 2012, Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms, Small, 8, 3016, 10.1002/smll.201200575 · DOI
  141. 2015, Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections, J. Controlled Release, 209, 150, 10.1016/j.jconrel.2015.04.028 · DOI · Paper page
  142. 2013, Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites, Adv. Mater., 25, 5706, 10.1002/adma.201302627 · DOI
  143. 2011, Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents, Int. J. Nanomedicine, 6, 877
  144. 2004, Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 48, 1320, 10.1128/AAC.48.4.1320-1328.2004 · DOI · Paper page
  145. 2007, Antimicrobial effects of silver nanoparticles, Nanomedicine, 3, 95, 10.1016/j.nano.2006.12.001 · DOI · Paper page
  146. 2009, The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver, Int. J. Antimicrob. Agents, 34, 103, 10.1016/j.ijantimicag.2009.01.017 · DOI · Paper page
  147. 2010, Pseudomonas aeruginosa biofilms in cystic fibrosis, Future Microbiol., 5, 1663, 10.2217/fmb.10.125 · DOI · Paper page
  148. 2016, Potent antimicrobial and antibiofilm activities of bacteriogenically synthesized gold-silver nanoparticles against pathogenic bacteria and their physiochemical characterizations, J. Biomater. Appl., 31, 366, 10.1177/0885328216646910 · DOI
  149. 2012, Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and in vitro investigation, Photochem. Photobiol., 88, 570, 10.1111/j.1751-1097.2012.01101.x · DOI

Cited by

See all 114

Metadata

Authors
Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L.
Affiliations
Binghamton University (US)
Corresponding author
Doiron, Amber L.
Venue
Nanotechnology Reviews
Published
2017-10-26
Volume
6
Issue
5
Pages
383-404
ISSN
  • 2191-9089 (ISSN-L)
  • 2191-9097
OpenAlex
W2557184343
Cited by
114
References
141
Citations by year
2026: 8 · 2025: 20 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 21 · 2020: 12 · 2019: 6 · 2018: 4
FWCI
1.73
Type
journal article
Language
en
Open access
Locations
  • Nanotechnology Reviews (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
nanoparticles, biofilm, biofilm-associated infections, chronic infection, antibiotic resistance, antibiofilm activity, biofilm eradication, nanoparticle characterization, nanotherapeutics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent developments in the use of nanoparticles for treatment of biofilms. https://app.cochat.ai/papers/10.1515/ntrev-2016-0054
The paper
Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L. (2017). Recent developments in the use of nanoparticles for treatment of biofilms. Nanotechnology Reviews. https://doi.org/10.1515/ntrev-2016-0054

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.